Becker JN, Hermann R, Wichmann J, Sonnhoff M, et al. Low skeletal muscle mass is predictive of dose-limiting toxicities in head and neck cancer patients undergoing low-dose weekly cisplatin chemoradiotherapy. PLoS One 2023;18:e0282015.
PMID: 36802403